health
March 12, 2026
Antibiotics need coordinated G7 investment
Grace Hampson on ways to address the worryingly thin pipeline of new effective drugs
TL;DR
- The pipeline for new antibiotics is worryingly thin, posing a significant health crisis.
- A fundamental market failure exists where limiting antibiotic use to essential cases reduces sales and company incentives for development.
- The UK's NHS-Nice "Netflix subscription model" provides a fixed annual payment to firms for access to new antibiotics, delinking revenue from volume.
- Coordinated G7 investment in incentivizing new antibiotic development would yield exceptional returns, saving millions of lives.
- Addressing antimicrobial resistance requires international political and societal priority, not just reliance on companies.
Continue reading the original article